Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Blackstone
BX
|
$404M |
| 2 |
Uber
UBER
|
$319M |
| 3 |
Bristol-Myers Squibb
BMY
|
$316M |
| 4 |
Danaher
DHR
|
$302M |
| 5 |
Honeywell
HON
|
$281M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$812M |
| 2 |
ULTI
Ultimate Software Group Inc
ULTI
|
$701M |
| 3 |
AGN
Allergan plc
AGN
|
$629M |
| 4 |
Humana
HUM
|
$380M |
| 5 |
Bank of America
BAC
|
$290M |
Sector Composition
| 1 | Technology | 24.72% |
| 2 | Healthcare | 17.4% |
| 3 | Financials | 12.88% |
| 4 | Industrials | 11.3% |
| 5 | Consumer Discretionary | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NUAN
1226
DELISTED
Nuance Communications, Inc.
NUAN
| $734K | ﹤0.01% |
53,064
-13,976
| -21% | -$193K |
|
1227
Nutanix
NTNX
$20.3B
| $732K | ﹤0.01% |
28,208
+3,310
| +13% | +$85.9K |
|
1228
Old Republic International
ORI
$9.99B
| $727K | ﹤0.01% |
32,457
+2,561
| +9% | +$57.4K |
|
1229
Usana Health Sciences
USNA
$569M
| $721K | ﹤0.01% |
9,074
+1,947
| +27% | +$155K |
|
1230
Innoviva
INVA
$1.29B
| $702K | ﹤0.01% |
48,218
-1,949
| -4% | -$28.4K |
|
1231
Vanguard Financials ETF
VFH
$12.8B
| $698K | ﹤0.01% |
10,115
-900
| -8% | -$62.1K |
|
1232
Healthcare Realty
HR
$6.36B
| $691K | ﹤0.01% |
25,176
-24,303
| -49% | -$667K |
|
1233
National Research Corp
NRC
$358M
| $682K | ﹤0.01% |
+11,842
| New | +$682K |
|
1234
FormFactor
FORM
$2.28B
| $657K | ﹤0.01% |
41,950
+15,573
| +59% | +$244K |
|
|
RDS.B
1235
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $644K | ﹤0.01% |
9,789
| – | – |
|
1236
Ashland
ASH
$2.48B
| $642K | ﹤0.01% |
8,030
-1,059
| -12% | -$84.7K |
|
1237
Lumentum
LITE
$10.5B
| $640K | ﹤0.01% |
11,988
+3,610
| +43% | +$193K |
|
1238
National Beverage
FIZZ
$3.68B
| $637K | ﹤0.01% |
28,542
+9,762
| +52% | +$218K |
|
|
AMED
1239
DELISTED
Amedisys
AMED
| $632K | ﹤0.01% |
5,207
+803
| +18% | +$97.5K |
|
1240
Ingersoll Rand
IR
$31.9B
| $626K | ﹤0.01% |
+18,096
| New | +$626K |
|
1241
Cameco
CCJ
$33.5B
| $625K | ﹤0.01% |
58,460
| – | – |
|
1242
National Health Investors
NHI
$3.73B
| $621K | ﹤0.01% |
7,956
-7,883
| -50% | -$615K |
|
1243
Choice Hotels
CHH
$5.24B
| $615K | ﹤0.01% |
7,073
+4,435
| +168% | +$386K |
|
|
KEM
1244
DELISTED
KEMET Corporation
KEM
| $614K | ﹤0.01% |
+32,619
| New | +$614K |
|
1245
Corcept Therapeutics
CORT
$7.45B
| $610K | ﹤0.01% |
54,692
-1,325
| -2% | -$14.8K |
|
1246
BlackBerry
BB
$2.29B
| $603K | ﹤0.01% |
80,635
-884
| -1% | -$6.61K |
|
|
PE
1247
DELISTED
PARSLEY ENERGY INC
PE
| $597K | ﹤0.01% |
31,420
| – | – |
|
1248
Methode Electronics
MEI
$255M
| $594K | ﹤0.01% |
20,800
+7,701
| +59% | +$220K |
|
1249
Vanguard Industrials ETF
VIS
$6.11B
| $589K | ﹤0.01% |
4,041
-400
| -9% | -$58.3K |
|
1250
Diageo
DEO
$59.1B
| $587K | ﹤0.01% |
3,409
| – | – |
|